The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Main Authors: | , , , , , , |
|---|---|
| Outros autores: | |
| Formato: | Conference item |
| Idioma: | English |
| Publicado: |
Elsevier
2020
|